0 Comentários
0 Compartilhamentos
286 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Biopharmaceutical Outsourcing: The Future of Cell and Gene Therapy ManufacturingThe development and manufacturing of cell and gene therapies have been revolutionized by the emergence of contract development and manufacturing organizations (CDMOs), which provide specialized expertise and infrastructure for the production of these complex therapies. Biopharmaceutical outsourcing enables companies to access the capabilities needed to bring innovative treatments to market,...0 Comentários 0 Compartilhamentos 453 Visualizações 0 Anterior
-
Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share, Growth and Forecast 2034In an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Comentários 0 Compartilhamentos 343 Visualizações 0 Anterior
-
Cell & Gene Therapy Contract Research Organizations Market Competitive Landscape and Future GrowthMarket Overview Polaris Market Research’s latest research report, titled Cell & Gene Therapy Contract Research Organizations Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies,...0 Comentários 0 Compartilhamentos 411 Visualizações 0 Anterior
-
Cell and Gene Therapy CDMO: The Future of Gene Therapy ManufacturingThe development and manufacturing of gene therapies have been revolutionized by the emergence of contract development and manufacturing organizations (CDMOs), which provide specialized expertise and infrastructure for vector production. Cell and gene therapy CDMOs enable biopharmaceutical companies to access the capabilities needed to bring gene therapies to market, accelerating the translation...0 Comentários 0 Compartilhamentos 375 Visualizações 0 Anterior
-
Cell and Gene Therapy Clinical Trials Market Growth, Global Trends, Size, Segmentation, Opportunities, Forecast Analysis By Fact.MRRockville, Maryland — October 1, 2026 — The cell and gene therapy clinical trials market is expected to expand from USD 14.3 billion in 2026 to USD 61.5 billion by 2036, advancing at a 15.7% CAGR over the forecast period. The market is being shaped by increasing clinical development activity, rising investment in advanced therapies, expanding healthcare infrastructure, and growing...0 Comentários 0 Compartilhamentos 11 Visualizações 0 Anterior
-
Cell and Gene Therapy Manufacturing Market Future Scope, Regulatory Windows and Forecast to 2033A new report titled “Global Cell and Gene Therapy Manufacturing Market Professional Report 2025-2033” has been added by Straits Research to its repository of research reports. The report analyzes and estimates the market on a global, regional, and country level. The report offers data from previous years along with an in-depth analysis from 2025 to 2033 on the basis of revenue (USD...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Global Cellular Starting Materials Market Trends Supporting Cell and Gene Therapy DevelopmentPolaris Market Research announces the release of its latest research report Cellular Starting Materials Market. The newly published report captures all the key forces influencing market transformation. As industries evolve amid technological shifts, economic disruptions, and regulatory changes, the study outlines how the market is responding and where it is headed. Designed to serve...0 Comentários 0 Compartilhamentos 87 Visualizações 0 Anterior
-
How Gene Therapy and Stem Cell Transplantation Are Driving the Wiskott Aldrich Syndrome Treatment MarketThe global Wiskott Aldrich Syndrome Treatment Market is expanding as healthcare providers, rare-disease specialists, and biotechnology companies develop advanced therapies for this inherited immune disorder. The market was valued at USD 17.65 billion in 2024 and is projected to reach USD 35.0 billion by 2032, growing at a CAGR of 8.94%. The Wiskott Aldrich Syndrome Treatment Market includes...0 Comentários 0 Compartilhamentos 468 Visualizações 0 Anterior
-
How Is Long-Term Ultra-Low Preservation Infrastructure Supporting Advanced Cell and Gene Therapy Storage?The growth of personalized cell therapies, specialized tissue engineering, and international bio-banking networks requires specialized cold storage systems capable of maintaining strict thermal control. Standard refrigeration equipment cannot protect fragile biological structures from structural crystallization and cellular degradation over extended periods. Cryogenic bio-freezers utilizing...0 Comentários 0 Compartilhamentos 209 Visualizações 0 Anterior
-
How Is Long-Term Ultra-Low Preservation Infrastructure Supporting Advanced Cell and Gene Therapy Storage?The growth of personalized cell therapies, specialized tissue engineering, and international bio-banking networks requires specialized cold storage systems capable of maintaining strict thermal control. Standard refrigeration equipment cannot protect fragile biological structures from structural crystallization and cellular degradation over extended periods. Cryogenic bio-freezers utilizing...0 Comentários 0 Compartilhamentos 241 Visualizações 0 Anterior
-
Manufacturing Hope: How Cell and Gene Therapy Manufacturing Is Advancing with CDMO PartnershipsThe Cell and Gene Therapy CDMO Market is experiencing explosive growth as cell and gene therapy manufacturing continues to advance with strategic CDMO partnerships. According to market reports, the global Cell and Gene Therapy CDMO Market was valued at USD 27.34 billion in 2024 and is projected to reach USD 95.6 billion by 2032, exhibiting an impressive CAGR of 16.94% during the...0 Comentários 0 Compartilhamentos 403 Visualizações 0 Anterior
-
Exosomes Market to Reach USD 912.33 Million by 2033, Growing at 14.7% CAGRThe global exosomes market size was valued at USD 265.51 million in 2024 and is anticipated to grow from USD 304.54 million in 2025 to reach USD 912.33 million in 2033, growing at a CAGR of 14.7% during the forecast period (2025–2033). According to Straits Research, this report provides a clear understanding of the Exosomes Market by analyzing its overall structure, key...0 Comentários 0 Compartilhamentos 4K Visualizações 0 Anterior
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Single-Use Bioprocessing Market: Demand, Trends & Future OpportunitiesSingle-Use Bioprocessing Market: Growth, Trends, Demand & Future Outlook to 2033 Single-Use Bioprocessing Market Snapshot The Global Single-Use Bioprocessing Market is witnessing rapid expansion as biopharmaceutical manufacturers increasingly adopt flexible, scalable, and cost-efficient manufacturing technologies. The market is projected to reach...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek